Follow Kristin's Journey From Cancer Victim To Mother

This analysis has created a controversy with avandia manufacturer glaxosmithkline insisting that dr. Quotas you accumulate more and more evidence that avandia has this problem and it is a very serious consequence namely a heart attack and death it puts a lot of pressure on the fda to do more. Ltbrgt ltbrgt upon review the food and drug administration in november concluded that the evidence against drugs was inconclusive. Quot ltbrgt ltbrgt in a statement glaxosmithkline said the new analysis was flawed because patients avandia given in the health program of ontario were usually patients who had not d amp other treatments. Of these patients have taken avandia. They tend to be sick patients face a higher risk of cardiovascular disease reference glaxo said.
Article Generated by: Blogger Post Content|Short Video Site